Skip to main navigation
Skip to Content
logo
  • Overview
  • Stock Information
    • Stock Quote and Chart
    • Historical Price Lookup
    • IRS Form 8937
  • SEC Filings
  • Corporate Governance
    • Governance Documents
    • Management Team
    • Board of Directors
    • Committee Composition
    • Investor FAQs
  • Company
    • Press Releases
    • Events & Presentations
    • Pipeline
  • Contact Us
  • ImmunityBio.com

Event

NantKwest and ImmunityBio investor call to discuss the Companies’ COVID-19 therapeutic and vaccine initiatives

May 27, 2020 12:00 PM EDT

To download the presentation, please click the link below.

Download Presentation (PDF)

To access the event, please click here.

IR Tools

Print Page
RSS Feeds
Email Alerts
logo
© 2021 ImmunityBio, Inc. All Rights Reserved.
A member of the NantWorks ecosystem of companies

Privacy Policy | Terms of Use

'Nantkwest’, ‘Conkwest’, ‘aNK’, ‘haNK’, ‘taNK’, ‘vaNK’, ’t-haNK’, ‘ceNK’, ‘M-ceNK’, ‘NK-92’, ‘Neukosome’, ‘Living Drugs in a Bag’, and ‘Nature’s First Responder’ are trademarks or registered trademarks of Nantkwest, Inc.
Anktiva is a trademark of ImmunityBio, Inc.
The Natural Killer Cell platform consists of investigational agents that are restricted by federal law to investigational use only.
The Natural Killer Cell platform is being investigated in multiple clinical trials across tumor sites.
The content of this website is protected by Title 17 of the U.S. Code and may not be reproduced in whole or in part by any means.

NantKwest

Visit ImmunityBio.com

Social icons